Favor Cyclicals Over Defensives Over The Coming Year
Publicado en
Global cyclical stocks gained ground versus their defensive counterparts this week in response to Pfizer’s vaccine efficacy news, setting a new post-March high. While cyclicals paused modestly on Wednesday as investors continued to digest the news, we expect…
¿Interesado en leer el Daily Insight completo?
Lee el análisis completo con acceso instantáneo.
Investigación BCA | Essentials
Concise macro insight that cuts through daily noise, helping clients stay informed on what matters in markets, why it matters, and how to talk about it, without spending hours reading research.
Mantente conectado con BCA
Recibe nuestros últimos eventos y análisis de investigación directamente en tu correo.